Vessel sprouting by migrating tip and proliferating stalk endothelial cells (ECs) is controlled by genetic signals (such as Notch), but it is unknown whether metabolism also regulates this process. Here, we show that ECs relied on glycolysis rather than on oxidative phosphorylation for ATP production and that loss of the glycolytic activator PFKFB3 in ECs impaired vessel formation. Mechanistically, PFKFB3 not only regulated EC proliferation but also controlled the formation of filopodia/lamellipodia and directional migration, in part by compartmentalizing with F-actin in motile protrusions. Mosaic in vitro and in vivo sprouting assays further revealed that PFKFB3 overexpression overruled the pro-stalk activity of Notch, whereas PFKFB3 deficiency impaired tip cell formation upon Notch blockade, implying that glycolysis regulates vessel branching.
INTRODUCTION
Vessel sprouting relies on the induction of endothelial cells (ECs) into specialized subtypes, each performing specific functions. Tip cells at the forefront of the vascular branch extend long filopodia and navigate but rarely proliferate, whereas trailing stalk cells proliferate to elongate the branch (Geudens and Gerhardt, 2011; Potente et al., 2011) . Once the vessel is perfused, ECs become quiescent phalanx cells. Several genetic factors coordinate tip, stalk, and phalanx cell phenotypes (Geudens and Gerhardt, 2011; Potente et al., 2011) . For instance, Notch signaling potently controls vessel branching by stimulating the stalk cell phenotype (Potente et al., 2011) . Hence, blockade of Notch signaling induces vascular hypersprouting, while activation of the Notch pathway causes the opposite effect. However, a role for metabolism in vessel sprouting has not been studied to date.
Only a limited number of reports have characterized the metabolic pathways in ECs in vitro, and even fewer reports have studied how EC metabolism regulates angiogenesis in vivo (Dobrina and Rossi, 1983; Harjes et al., 2012; Laing et al., 1992; Mertens et al., 1990; Peters et al., 2009) . Despite immediate access to oxygen in the blood, ECs have been reported to rely on glycolysis (Dobrina and Rossi, 1983; Krü tzfeldt et al., 1990; Mertens et al., 1990) . However, other studies have claimed that glutamine and fatty acids were more essential substrates, suggesting an important role for oxidative phosphorylation and mitochondrial respiration (Leighton et al., 1987; Spolarics et al., 1991) . How critical glycolysis versus respiration is for EC behavior in vivo is unknown.
One of the rate-limiting checkpoints of the glycolytic flux is the conversion of fructose-6-phosphate (F6P) to fructose-1,6-bisphosphate (F1,6P 2 ) by 6-phosphofructo-1-kinase (PFK-1). Phosphofructokinase-2/fructose-2,6-bisphosphatase (PFKFB) enzymes synthesize fructose-2,6-bisphosphate (F2,6P 2 ), an allosteric activator of PFK-1 and the most potent stimulator of glycolysis (Van Schaftingen et al., 1982) . Of all PFKFB isoenzymes, PFKFB3 has a much higher kinase activity than bisphosphatase activity (700-fold), thus favoring the production of intracellular F2,6P 2 levels and controlling its abundance (Yalcin et al., 2009b) . By contrast, the PFKFB4 isoenzyme has a much weaker kinase activity and has been reported to stimulate or inhibit glycolysis (Goidts et al., 2012; Ros et al., 2012) . Silencing as well as pharmacological inhibition of PFKFB3 in tumor cells reduces tumor cell glycolysis and growth (Chesney et al., 1999; Clem et al., 2008) . However, aside from a single study documenting its expression in ECs (Bando et al., 2005) , the role of PFKFB3 in angiogenesis has not been studied. Here, we investigated whether PFKFB3-driven glycolysis regulates vessel sprouting and whether it affects tip versus stalk cell formation.
RESULTS

Endothelial Cells Are Highly Glycolytic
We first explored which metabolic pathway is critical for ECs and measured the flux of metabolic pathways using radioactive tracer-labeled substrates in EC monolayers. Arterial, venous, lymphatic, and microvascular ECs were highly glycolytic (Figure 1A) . Glycolysis was even higher in hemangioma and angiosarcoma cells ( Figure 1B ). Glycolysis levels in ECs were largely comparable to those in tumor cells but much higher than in various other healthy cells (Figures 1A and 1B) . For most experiments, human umbilical venous endothelial cells (HUVECs) were used (further denoted as ''ECs''). Notably, when compared to glucose oxidation (GO), fatty acid oxidation (FAO), and glutamine oxidation (QO), glycolytic flux was >200-fold higher ( Figure 1C ). Mitochondrial respiration was lower in ECs than in other oxidative cell types ( Figure 1D ). Calculation of the amount of ATP showed that glycolysis generated up to 85% of the total cellular ATP content. Overall, glycolysis is the predominant bioenergetic pathway for ECs.
PFKFB3 Regulates Glycolysis in ECs
To explore the functional importance of glycolysis in ECs, we focused on PFKFB3, the most abundant isoenzyme in various EC subtypes (Figures S1A-S1D available online). PFKFB3 silencing in EC monolayers with a lentiviral vector encoding a PFKFB3 small hairpin RNA (shRNA) (PFKFB3 KD ) lowered PFKFB3 protein levels by 76% ( Figure S1E ). PFKFB3 knockdown decreased F2,6P 2 levels ( Figure S1F) ; it also reduced glycolytic flux but by no more than 35% ( Figure 1E ). Similar effects were obtained when using PFKFB3-selective RNA interference (RNAi) oligomers, which lowered PFKFB3 protein levels by 84% ( Figure S1G ) and reduced glycolysis by 40% ( Figure 1E ). PFKFB3 silencing also reduced glycolysis in arterial and microvascular ECs, as well as in hemangioma and angiosarcoma cells (Figure 1E) . Furthermore, PFKFB3 knockdown decreased F2,6P 2 levels in arterial ECs (by 60%) and in hemangioma cells (by 66%).
PFKFB3 Stimulates Vessel Sprouting In Vitro
To study the role of PFKFB3 in vessel formation in vitro, we first used EC spheroids. PFKFB3
KD decreased sprout numbers and shortened sprout length ( Figures 1F-1I ). Conversely, overexpression of PFKFB3 using a lentiviral vector encoding PFKFB3 (PFKFB3 OE ) enhanced glycolysis and increased sprout numbers and length (Figures S1H-S1L). The reduced sprouting of PFKFB3-silenced ECs was partly due to an impairment of EC proliferation ( Figure 1J ) (see below for effects on EC motility).
In contrast, poisoning mitochondrial respiration by using inhibitors at concentrations that lower oxygen consumption did not inhibit vessel sprouting (Figures 1K and 1L ; Figure S1M ). Conversely, supplements of pyruvate or NADH at concentrations that increased the oxygen consumption rate failed to affect vessel sprouting and did not rescue sprouting upon PFKFB3 silencing (Figures 1M and 1N ; Figure S1N ). Thus, loss-and gain-of-function studies highlighted that glycolysis, rather than respiration, regulates vessel sprouting.
PFKFB3 Gene Deletion in ECs Causes Vascular Defects In Vivo
We then studied the effects of PFKFB3 deficiency on vessel formation in the postnatal mouse retina. We generated PFKFB3 lox/lox mice and crossed them with VE-cadherin(PAC)-Cre ERT2 mice, an EC-specific Cre-driver line (Benedito et al., 2009 ), termed PFKFB3 vDEC mice. To evaluate the recombination efficiency, we crossed PFKFB3 vDEC mice with mT/mG mice, a double-fluorescent Cre reporter line that expresses membrane-targeted Tomato (mT) prior to Cre-mediated excision and GFP (mG) after excision. Treatment of triple-transgenic pups with tamoxifen at postnatal days 1-4 inactivated PFKFB3 in 50%-85% of ECs, and the PFKFB3-lox allele was correctly recombined ( Figure S2A ). EC loss of PFKFB3 diminished the number of branch points, distal sprouts with filopodia and filopodia (Figures 2A-2H ). Distal sprouts in PFKFB3 vDEC mice also had fewer side connections. The radial expansion of the vascular plexus was reduced in PFKFB3 vDEC mice ( Figure 2I ) to similar levels as in other models with sprouting defects (Graupera et al., 2008; Phng et al., 2009 ). Similar results were obtained when using Pdgfb-Cre ERT2 mice, another EC-selective inducible Cre-driver line (Claxton et al., 2008) (Figures S2A-S2G We also analyzed the role of PFKFB3 in vessel formation in the hindbrain, another model used to study angiogenesis (Fantin et al., 2013) . To assess whether PFKFB3 deficiency affected this process, we generated high (>90%) chimeric mice by injecting mCherryRed + wild-type (WT) or PFKFB3 À/À ES cells in CD-1 blastocysts. The vascular area in the ventricular zone was reduced by 40% in embryonic day 10.5 (E10.5) somite-matched PFKFB3 À/À chimeras ( Figures 2P-2R ), indicating that PFKFB3 regulated vessel sprouting.
PFKFB3 Silencing Impairs Lamellipodia Formation
We then explored whether the vascular defects in mice lacking endothelial PFKFB3 were also due to EC motility defects, aside See also Figure S1 .
from the aforementioned EC proliferation defects. Because lamellipodia are critical for EC motility, we quantified lamellipodia formation. Time-lapse video imaging of GFP + ECs revealed that these cells formed lamellipodial projections over large areas and had leading-edge projections with a front-to-back distribution, resulting in cell body displacement ( Figures 3A, 3D , and 3G; Movie S1A). In contrast, PFKFB3-silenced cells formed smaller lamellipodia and often only formed irregularly bulging protrusions ( Figures 3B, 3E , and 3G; Movie S1B). Lamellipodia in PFKFB3-silenced cells were also more transient, and the more randomly projecting disoriented protrusions were unable to produce cell displacement (Figures 3C and 3F ; Movie S1B). These cells also formed fewer and shorter filopodia ( Figures 3H-3M ). PFKFB3 silencing also impaired EC motility, as it reduced EC migration and sprout formation in the presence of mitomycin C (MitoC), which blocks EC proliferation ( Figures 3N-3P) , and decreased the EC migration velocity ( Figure 3Q ). Moreover, video imaging of random cell-motility tracks of individual ECs revealed a greater directional persistence of movement for control than PFKFB3-silenced cells ( Figures 3R and 3S ), presumably because PFKFB3-silenced ECs were unable to form sustained lamellipodia.
Tip and Stalk Cell Signals Regulate PFKFB3 Levels
We then explored how PFKFB3 regulated vessel sprouting mechanistically, and therefore first analyzed whether sproutinggoverning signals affected PFKFB3 expression. Indeed, sprouting-inducing signals (VEGF, FGF2) increased PFKFB3 expression and glycolysis ( Figure 4A ), whereas the sprouting-limiting signal DLL4 (activating Notch) caused opposite effects ( Figure 4B ). However, PFKFB3 levels did not alter the genetic tip versus stalk cell signature of ECs in baseline conditions ( Figures 4C and 4D ). Furthermore, PFKFB3 levels did not alter the molecular signature of ECs that were genetically or pharmacologically instructed to the tip or stalk cell phenotype. Indeed, we pretreated ECs with DAPT to promote a tip cell phenotype, as evidenced by the upregulation of VEGFR2/KDR (tip-cell-enriched gene) by 69% and downregulation of VEGFR1 (stalk-cell-enriched signal) by 38%. However, PFKFB3 silencing did not alter the molecular signature of Notch-silenced cells ( Figure 4C ). Conversely, we also overexpressed the Notch intracellular domain (NICD) to promote a stalk cell phenotype, as evidenced by the upregulated Notch-target genes ( Figure 4D ). In stalk-promoted cells, PFKFB3 overexpression did not alter gene expression ( Figure 4D ).
PFKFB3 Levels Influence the Tip Cell Position
We then assessed whether PFKFB3 levels influenced the cellautonomous ability of ECs to form tip cells. We therefore generated mosaic spheroids by mixing ECs expressing normal or silenced levels of PFKFB3 and assessed which ECs were present at the tip. PFKFB3 silencing was achieved by lentiviral transduction of shPFKFB3 and EGFP (PFKFB3 KD/GFP ). These cells were mixed in a 1:1 ratio with WT cells expressing mCherry (WT RED ). In control spheroids, generated by mixing WT RED and EGFP-positive WT cells (WT GFP ), comparable numbers of each genotype were identified at the tip ( Figures  4E and 4G ). However, when PFKFB3 KD/GFP and WT RED cells were mixed, PFKFB3
KD/GFP cells were less frequently present at the tip ( Figures 4F and 4G ). Similar results were obtained when using MitoC-treated ECs, indicating that the reduced tip cell behavior of PFKFB3 KD/GFP cells was not due to impaired proliferation ( Figure S3A ). Even when PFKFB3 KD/GFP and WT RED cells were mixed at a 9:1 ratio, fewer PFKFB3 KD/GFP cells were found at the tip ( Figure S3B ). Conversely, elevated PFKFB3 Figure S3 . levels improved tip cell formation, though only modestly ( Figure S3C ).
PFKFB3 Silencing Impairs Tip Cell Activity
To further document the importance of PFKFB3 during tip cell competition, we inhibited Notch signaling (which favors the tip cell phenotype) and examined whether PFKFB3 silencing affected their tip position. Spheroids of ECs in which Notch signaling was blocked by RNAi-mediated silencing (NOTCH1 KD/GFP ) or DAPT treatment formed more numerous and longer sprouts (Figures 4H and 4I ; Figures S3D and S3E ), but PFKFB3 silencing in NOTCH1 KD/GFP or DAPT-treated cells reduced the number and length of the vascular sprouts induced by Notch inhibition (Figures 4H and 4I ; Figures S3D and S3E) .
We also used mosaic spheroids containing a 1:1 mixture of WT RED and NOTCH1 KD/GFP cells. NOTCH1 KD/GFP cells were more often detected at the tip ( Figure 4J ). However, when PFKFB3 was silenced in NOTCH1 KD/GFP cells, the doublesilenced cells were no longer preferentially present at the tip ( Figure 4J ). Thus, ECs lacking the genetic determinant of the stalk phenotype were less able to reside at the tip when their PFKFB3 levels were reduced. Similar results were obtained after treatment with MitoC, indicating that the observed findings were not only attributable to differences in proliferation ( Figure S3F ).
PFKFB3 Overexpression Improves Tip Cell Behavior
We further analyzed whether elevated PFKFB3 levels could overrule the stalk-cell-inducing activity of NICD. Vascular sprouting was impaired in spheroids of ECs overexpressing NICD (NICD OE ) ( Figures 4K and 4L) . Notably, however, overexpression of PFKFB3 in NICD OE cells overcame NICD's activity and restored vascular sprouting ( Figures 4K and 4L OE/GFP cells were present more frequently at the tip (Figures 4N and 4O ). Mitotically inactivated ECs showed similar responses ( Figure S3H ).
PFKFB3 Promotes the Tip Cell Position In Vivo
We analyzed the hindbrain vasculature of E10.5 somitematched chimeras generated by injecting mCherryRed + WT or PFKFB3 À/À ES cells into CD-1 blastocysts. Figures 5N-5V ). Thus, PFKFB3 was able to overcome NICD's pro-stalk activity.
Compartmentalization of PFKFB3
The aforementioned results show that PFKFB3 silencing affected EC motility, a process requiring remodeling of the cytoskeleton. Because respiration did not affect sprouting, we explored a possible link between glycolysis and the actin cytoskeleton. To analyze the cellular distribution of mitochondria in tip cells in vivo, we generated a transgenic Mito EC : mouse expressing GFP in EC mitochondria. Isolectin-B4 staining of retinal ECs in vivo showed that mitochondria in tip cells were present in the perinuclear cytosol and in cytoplasmic protrusions at the base from where filopodia projected but were excluded from filopodia ( Figures 6A-6C) . Staining for the mitochondrial marker TOMM20 ( Figure 6D ) and time-lapse video imaging of mCherry + ECs in which mitochondria were labeled with Mito:EGFP (Movie S2) confirmed that mitochondria were excluded from lamellipodia. We then analyzed the subcellular localization of glycolytic enzymes (including PFKFB3) by immunostaining. In spontaneously moving ECs, PFKFB3 was detectable in the cell body and lamellipodia ( Figure 6E ). Abundant PFKFB3 immunoreactivity was detected in the perinuclear cytosol. When analyzing PFKFB3 immunoreactive levels in a 300 nm single optical stack after pseudocolor conversion, PFKFB3-immunoreactive levels were comparable in lamellipodia and the cell body ( Figure 6F ). Quantification of PFKFB3 and F-actin immunoreactivity levels in single-stack images showed that PFKFB3 was enriched with F-actin in membrane ruffles at the leading front of lamellipodia, known to contain a meshwork of polymerized actin filaments ( Figures 6G and 6H) . Additional glycolytic enzymes, including the ATP-generating pyruvate kinase (PK) and phosphoglycerate kinase (PGK) and others, also colocalized with F-actin in lamellipodial ruffles (Figures S4A-S4H) . Notably, unlike PKM2, PKM1, which is involved in ATP production rather than biosynthesis of macromolecules, also colocalized in lamellipodia ( Figures S4I  and S4J ). Immunoprecipitation of PFKFB3 followed by immunoblotting for b-actin ( Figure 6I ) or mass spectrometry (Table S1) confirmed that PFKFB3 interacts with actin. Moreover, PFKFB3 was detectable in both the G-and F-actin cellular fractions ( Figure 6J ) but was more abundant in the F-actin fraction of motile than quiescent contact-inhibited ECs ( Figure 6K) . Notably, PFKFB3 was present in the perinuclear cytosol in contact-inhibited ECs but was relocated into the lamellipodia, protrusions, and cell-cell bridges in motile ECs ( Figures S4K  and S4L) .
Furthermore, time-lapse video imaging after transfecting the ATP biosensor GO-ATeam in spontaneously motile ECs revealed high ATP levels in lamellipodia in leading membrane ruffles (Figure 6L ; Movie S3). Compared to control cells, PFKFB3-silenced cells had 55% ± 5% fewer lamellipodial ATP hotspots, which were also 49% ± 9% smaller and contained 57% ± 2% lower levels of ATP (n = 4-5; p < 0.001) ( Figure 6M ). However, respira- tion blockers did not reduce lamellipodia ATP levels in the membrane ruffles ( Figure 6N ).
Cellular Adaptation to PFKFB3
Silencing Finally, we explored whether the effects of PFKFB3 blockade were due to a general energy hypometabolism. However, PFKFB3 silencing did not alter the energy charge and ATP levels ( Figures 7A and 7B) , nor did it induce cell death as analyzed by measuring activated caspase 3 ( Figures 7C and 7D ) or LDH release (data not shown). PFKFB3-silenced cells showed no signs of endoplasmic reticulum, energy, or oxidative stress or of autophagy ( Figures 7E-7H ). PFKFB3 silencing did also not increase glucose oxidation and did not induce a switch to fatty acid oxidation or respiration ( Figures 7I and 7J ), which would be expected to occur when cells suffer severe energy deprivation from the blockage of glycolysis and need to compensate for such cellular energy stress. PFKFB3-silenced ECs were thus not in energy distress but rather adapted to a new metabolically balanced state. To maintain ATP levels, PFKFB3-silenced ECs decreased ATP consumption, as evidenced by a lower ADP/ATP ratio ( Figure 7K ) and reduced protein synthesis ( Figure 7L ) and EC proliferation (see above), all high-energy-demanding processes. Nonetheless, PFKFB3 silencing maintained extracellular matrix production ( Figure 7M ), promoted EC quiescence ( Figure 7N) , and increased the oxidative pentose phosphate pathway (oxPPP) (Figure 7O ), thus showing that PFKFB3 knockdown did not cause general energy hypometabolism but rather suppressed the hypermetabolism induced by vessel sprouting. In conditions of stress, PFKFB3-silenced ECs even increased fatty acid oxidation (Figure 7P) , likely to ensure redox homeostasis (Jeon et al., 2012) . Figure S4 , Movies S2 and S3, and Table S1 .
DISCUSSION Endothelial Cells Are Highly Glycolytic
ECs generated up to 85% of their ATP from glycolysis and were more glycolytic than other healthy cell types. In line with reports that ECs have a smaller mitochondrial volume fraction (5%) than oxidative hepatocytes (30%) and that mitochondria in ECs function as signaling hubs rather than metabolic powerhouses (Groschner et al., 2012) , the flux through glucose, fatty acid, and glutamine oxidation in ECs was <1% of the glycolytic flux. The importance of glycolysis for ECs was illustrated by findings that PFKFB3 silencing reduced vessel sprouting, whereas inhibition or stimulation of respiration had no effect.
The dependence of ECs on glycolysis is at first sight surprising because quiescent ECs are in immediate contact with oxygen in the blood. Hence, ECs are exposed to sufficient oxygen for oxidative metabolism, yet they prefer aerobic glycolysis. This is likely due to various reasons. First, by consuming little oxygen, they can transfer more oxygen to perivascular cells. Second, when sprouting into avascular tissues, ECs become exposed to low levels of oxygen and glucose. Because glucose diffuses further away from vessels than oxygen (Buchwald, 2011; Gatenby and Gillies, 2004) , ECs can still rely on anaerobic glycolysis to form vessels. Third, by maintaining a low oxidative metabolism, ECs minimize the production of reactive oxygen species, thereby providing protection against their high-oxygen milieu. (O) PFKFB3 silencing increased the flux through the oxidative pentose phosphate pathway (oxPPP) (mean ± SEM; n = 3; p < 0.05).
(P) PFKFB3 silencing increased fatty acid oxidation under low-glucose (1 mM and 0.1 mM) conditions (mean ± SEM; n = 5; *p < 0.05).
Fourth, glycolysis generates ATP more rapidly than oxidative metabolism, allowing ECs to meet the energy demands for dynamic rapid changes in motility. Finally, the glycolysis side pathways are necessary for the biosynthesis of macromolecules needed for cell mass duplication during cell division.
PFKFB3-Driven Glycolysis Regulates Sprouting
Silencing of PFKFB3 impaired vessel sprouting. These defects are due to effects on both migrating tip and proliferating stalk cells. In agreement with findings that cell proliferation requires glycolysis (Lunt and Vander Heiden, 2011) , PFKFB3 inactivation reduced EC proliferation, implying that the impaired vessel formation was at least partially due to proliferation defects. However, PFKFB3 is also important for EC motility. First, the tip-cell-activating signal VEGF upregulated the levels of PFKFB3 and glycolysis, whereas the pro-stalk cell signal Notch had opposite effects. Second, PFKFB3 blockade suppressed whereas PFKFB3 overexpression stimulated the sprouting of mitotically inactivated ECs in spheroids. Furthermore, PFKFB3 silencing impaired the motility, lamellipodia/filopodia formation, and directional migration of EC monolayers, which could contribute to the impaired vessel outgrowth and branching in mice with endothelial PFKFB3 deficiency. Third, in mosaic competition assays in vitro (using mitotically inactivated cells) and in vivo, ECs with silenced PFKFB3 levels were underrepresented at the tip in baseline and in tip-cell-favoring conditions, whereas PFKFB3 overexpression promoted the ability of ECs to form tip cells in baseline conditions in some assays and promoted tip cell formation of cells overexpressing the pro-stalk cell signal NICD. Notably, relative PFKFB3 levels did not alter the relative expression levels of tip or stalk cell genes, implying that a change in PFKFB3-driven glycolysis alone sufficed to promote tip cell activity. It is worth noting that no other signal has so far been reported to overcome NICD's potent pro-stalk cell activity, raising the question whether regulation of metabolism is a (perhaps even ''the'') key activity of Notch driving stalk cell formation. Given that tip and stalk cells dynamically interchange positions (Jakobsson et al., 2010) , we speculate that an increased level of glycolysis does not permanently convert stalk cells into a fixed tip cell phenotype, but rather that varying levels of glycolysis dynamically codetermine the fluid tip versus stalk cell phenotype. These findings also raise other intriguing questions, such as for instance whether tip cells can only stay at the tip for as long as they have sufficient glycolysis. In any case, in parallel to control by genetic signals, PFKFB3-driven glycolysis also regulates vessel sprouting.
Compartmentalization of Glycolysis with Actin Cytoskeleton Remodeling
Filopodia and lamellipodia are essential for tip cells. Contraction and protrusion of these structures rely on actin cytoskeleton remodeling and require hydrolysis of large amounts of ATP. Mitochondria (0.5 to >4.0 mm) are too bulky to fit into thin filopodia and lamellipodia (250 nm wide and high, respectively) but are mostly present in the perinuclear cytosol, distant from the filopodial tip, which can be up to 10 mm long. Diffusion of ATP from distant mitochondria in the perinuclear cytosol may thus not be able to support the high and rapidly changing ATP demands for sustained motor activity at the tip.
Several lines of evidence suggest that glycolytic enzymes are compartmentalized with F-actin in lamellipodia during vascular sprouting. First, PFKFB3 and other glycolytic enzymes (including those generating ATP) were relocated from the perinuclear cytosol in contact-inhibited ECs into lamellipodia and cell protrusions and were enriched in leading membrane ruffles of motile cells. Interestingly, the pyruvate kinase isoenzyme involved in ATP production (PKM1) rather than macromolecular biosynthesis (PKM2) was present in lamellipodia. Second, ATP biosensor imaging revealed that lamellipodia contained ''ATP hotspots,'' which were reduced when PFKFB3 was silenced, but not when respiration was blocked. Third, vessel branching was affected by inhibiting or stimulating glycolysis, but not by altering respiration. Fourth, PFKFB3 was associated with F-actin, and this fraction increased during EC migration.
The use of glycolysis to generate energy for motile structures may seem counterintuitive, as nearly 20-fold less ATP is produced per unit of glucose by glycolysis than by oxidative phosphorylation. Several reasons can explain this phenomenon. First, despite a low intrinsic yield, the yield of ATP generation by glycolysis can exceed that by glucose oxidation, as long as glucose is not limiting (DeBerardinis et al., 2008; Vander Heiden et al., 2009) . Second, compartmentalization of glycolysis with F-actin offers advantages. By creating a ''glycolytic hub,'' glycolytic enzymes are arranged on a cytomatrix in an assembly line, where metabolic substrates are passed from one enzyme to the next. Glycolytic enzymes are activated by actin and help in assembling actin microfilaments (Real-Hohn et al., 2010) . The enzyme proximity and activation by actin favor maximal rates of reaction (al-Habori, 1995) . Third, rapid extension/retraction of filopodia and lamellipodia may create an ATP drain for the cell body. Localizing the ATP supply to compartments where ATP is consumed can prevent catastrophic ATP depletion.
The link between glycolysis and actin is evolutionarily conserved, as glycolysis fuels other motile structures such as flagella of micro-organisms, tentacles of hydra, or cilia of eukaryotic cells (Baquer et al., 1975; Hereng et al., 2011; Pavlova, 2010) . The relevance of this link is underscored by findings that expression of aldolase, incapacitated to bind actin, paralyzes fruit flies (Wojtas et al., 1997) . PFKFB3 blockade might reduce angiogenesis also via other mechanisms. For instance, lactate stimulates angiogenesis via activation of HIF-1a and upregulation of VEGFR2 (Hunt et al., 2007) or via inhibition of the oxygen sensor PHD2, activating a proangiogenic nuclear factor kB/interleukin-8 program (Vé gran et al., 2011) . The reduced lactate levels upon PFKFB3 blockade could thus also suppress angiogenesis via these mechanisms. Also, PFKFB3 has been proposed to control cell proliferation via glycolysis-independent nuclear activities (Yalcin et al., 2009a) . While perhaps relevant to explain the effects on EC proliferation, the effects of PFKFB3 on EC motility are more likely due to compartmentalization of glycolytic enzymes in the lamellipodia.
General Implications
To date, only genetic signals have been considered to control vessel sprouting. Our findings add an extra dimension to this traditional concept and imply that metabolism also controls vessel sprouting. Aside from a genetic signature, tip and stalk cells thus likely also have a metabolic signature. While our study documented a role for glycolysis, other metabolic pathways might also influence vessel formation. In addition, it will be interesting to explore whether targeting PFKFB3 can reduce pathological angiogenesis.
EXPERIMENTAL PROCEDURES
More details can be found in the Extended Experimental Procedures.
Cell Culture and In Vitro Functional Assays
Freshly isolated primary HUVECs were used for metabolic evaluation, proliferation, migration, motility, and spheroid capillary sprouting assays and in cell-cycle assessments.
RNA and Protein Analysis RNA expression analysis was done by quantitative RT-PCR. Immunoblotting of proteins and immunohistochemistry was performed using the antibodies listed in the Extended Experimental Procedures.
Metabolic Assays
Glycolysis and oxidation of other substrates were determined using radioactively labeled tracers. Tg(fli1:EGFP) y1 zebrafish (Lawson and Weinstein, 2002) were subjected to Tol2-based transgenic overexpression. Quantification of sprouting of ISVs was done as explained in the Extended Experimental Procedures. Tamoxifen was injected intraperitoneally in mouse pups daily from postnatal day 1 to day 4. Eyes were fixed at postnatal day 5, and retinal flat mounts were prepared for vascular analysis as described (Phng et al., 2009 ). Embryonic hindbrain angiogenesis was assessed in E10.5-E11.5 embryos as described (Fantin et al., 2013) . Experimental animal procedures were approved by the Institutional Animal Care and Research Advisory Committee of the University of Leuven.
Animal Models of Angiogenesis
Statistics
Data represent mean ± SEM of representative experiments unless otherwise stated. Unless otherwise indicated, statistical significance was calculated by standard t test (Prism v4.0b), and phenotype severity distributions were analyzed by the chi-square test. Estimated means, SEMs, and significance levels were calculated with the general linear model univariate statistical model (SPSS), considering experiment as covariate. p < 0.05 was considered as statistically significant.
ACCESSION NUMBERS
The microarray data have been deposited in the Gene Expression Omnibus (Edgar et al., 2002) under accession number GSE45750 (http://www.ncbi. nlm.nih.gov/geo/query/acc.cgi?acc=GSE45750). 
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